Latest Breaking News On - Matthew chandler - Page 16 : comparemela.com

Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity

Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomMatthew chandler rob patrickTim metcalfe grahamCompany new ordinaryEuropean union withdrawalStrand hanson limited nominated adviserBiodexa pharmaceuticalsEdison group us investor relationsFinancial conduct authorityLondon stock exchangeAdvisory limited financialWall streetNew ordinary sharesEuropean unionHanson limited

Investegate |Biodexa Pharma Announcements | Biodexa Pharma: Exercise of Warrants and Issue of Equity

Investegate announcements from Biodexa Pharma, Exercise of Warrants and Issue of Equity

United kingdomCity ofMatthew chandler rob patrickTim metcalfe grahamBiodexa pharmaceuticalsCompany new ordinaryEuropean union withdrawalEdison group us investor relationsAdvisory limited financialStrand hanson limited nominated adviserLondon stock exchangeNew ordinary sharesEuropean unionHanson limitedNominated adviserMatthew chandler

Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue

Biodexa Pharmaceuticals PLC Announces Exercise of Warrants and Issue .

United kingdomCity ofTim metcalfe grahamMatthew chandler rob patrickNews networkEdison group us investor relationsFinancial conduct authorityLondon stock exchangeEuropean union withdrawalCompany new ordinaryAdvisory limited financialStrand hanson limited nominated adviserBiodexa pharmaceuticalsVoting rightsNew ordinary sharesEuropean union

Investegate |Midatech Pharma PLC Announcements | Midatech Pharma PLC: R&D Programme Focused on Leptomeningeal Disease

Investegate announcements from Midatech Pharma PLC, R&D Programme Focused on Leptomeningeal Disease

United kingdomUnited statesCity ofDmitry zamoryakhinMatthew chandler rob patrickTim metcalfe grahamEdison group us investor relationsAdvisory limited financialMidatech pharmaStrand hanson limited nominated adviserExchange commissionLondon stock exchangePreclinical rd programme focusedChemoresistant ovarianIntj molHanson limited

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

United kingdomUnited statesCity ofMatthew chandler rob patrickMidatech pharma plcviewDmitry zamoryakhinTim metcalfe grahamEdison group us investor relationsStrand hanson limited nominated adviserLondon stock exchangeMidatech pharmaAdvisory limited financialExchange commissionChemoresistant ovarianIntj molHanson limited